Cancer Cell International

Table 1 Association between linc00473 expression and clinicopathological characteristics of CCA patients

From: Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation

	No. of patients (n)	linc00473 expression		p-value
	No. of patients (n)	High (n)	Low (n)	p-value
Gender
Male	26	15	11	0.554
Female	34	17	17
Age in years
< 60	19	12	7	0.299
≥ 60	41	20	21
Tumor location
Intrahepatic	16	11	5	0.149
Extrahepatic	44	21	23
Tumor size
< 3 cm	35	10	25	0.001
≥ 3 cm	25	18	7
Lymph node invasion
Positive	38	11	27	0.006
Negative	22	17	5
TNM stage
I–II	27	7	20	0.001
III–IV	33	25	8
Differentiation grade
Well/moderately	25	13	12	0.943
Poorly/undifferentiated	35	18	16
HBV infection
Positive	18	10	8	0.621
Negative	42	22	20
Serum CEA level (ng/ml)
> 5	38	22	16	0.352
≤ 5	22	10	12
Serum CA19-9 level (µ/ml)
> 37	39	24	15	0.083
≤ 37	21	8	13

TNM stage Tumor-Node-Metastasis stage, CEA carcino embryonie antigen, CA19-9 carbohydrate antigen 19-9, HBV Hepatitis B virus

Back to article page

ISSN: 1475-2867

Contact us

General enquiries: journalsubmissions@springernature.com